Surviving sepsis campaign: Guideline clarification

Critical Care Medicine

Volumn 36, Issue 8, 2008, Pages 2490-

  Seeling, Matthes ^a   Eggers, Verena ^a   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; NORADRENALIN; VASOCONSTRICTOR AGENT;

CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; DISEASE SEVERITY; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL; MORTALITY; NOTE;

HUMANS; PRACTICE GUIDELINES AS TOPIC; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 85049057953     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31818115c5     Document Type: Letter

References (5)

1. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
2. Patel GP, Balk RA: Choice of vasopressor in septic shock: Does it matter? Crit Care 2007; 11:174
3. Annane D, Vignon P, Renault A, et al: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet 2007; 370:676-684
4. Atkins D, Best D, Briss PA, et al: Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490
5. Grilli R, Magrini N, Penna A, et al: Practice guidelines developed by specialty societies: The need for a critical appraisal. Lancet 2000; 355:103-106